We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+26.21%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$770M
AUM Growth
+$142M
Cap. Flow
+$8.71M
Cap. Flow %
1.13%
Top 10 Hldgs %
48.86%
Holding
67
New
8
Increased
35
Reduced
18
Closed
4

Top Buys

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$20.9M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$20.3M
3
DVAX
Dynavax Technologies
DVAX
+$13.3M
4
HALO icon
Halozyme
HALO
+$8.64M
5
TAK icon
Takeda Pharmaceutical
TAK
+$8.31M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$28.4M
2
VCYT icon
Veracyte
VCYT
+$14.3M
3
ARRY
Array Biopharma Inc
ARRY
+$13.2M
4
NEO icon
NeoGenomics
NEO
+$10.5M
5
OMCL icon
Omnicell
OMCL
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 75.14%
2 Communication Services 4.96%
3 Financials 0.82%
4 Energy 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
$54.2M 7.04%
2,221,721
-632,105
-22% -$13.2M
IONS icon
2
Ionis Pharmaceuticals
IONS
$8.6B
$49.6M 6.45%
611,162
+21,152
+4% +$1.36M
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$47.3M 6.14%
2,743,479
+228,927
+9% +$3.62M
OMCL icon
4
Omnicell
OMCL
$1.61B
$42.2M 5.48%
522,049
-138,606
-21% -$10.4M
MODN
5
DELISTED
MODEL N, INC.
MODN
$38.2M 4.96%
2,175,594
+449,190
+26% +$7.18M
NEO icon
6
NeoGenomics
NEO
$1.96B
$32.8M 4.27%
1,604,611
-603,577
-27% -$10.5M
HBIO icon
7
Harvard Bioscience
HBIO
$27.5M
$30.5M 3.96%
707,024
+6,065
+0.9% +$220K
HRTX icon
8
Heron Therapeutics
HRTX
$93.9M
$27.2M 3.53%
1,112,966
+287,697
+35% +$7.53M
SPNE
9
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$27.1M 3.53%
1,800,235
+15,164
+0.8% +$234K
IMMU
10
DELISTED
Immunomedics Inc
IMMU
$27M 3.51%
1,404,713
+44,433
+3% +$716K
NKTR icon
11
Nektar Therapeutics
NKTR
$2.39B
$25.6M 3.33%
50,894
+2,212
+5% +$1.31M
ATRC icon
12
AtriCure
ATRC
$1.92B
$24.5M 3.18%
914,307
-51,490
-5% -$1.56M
HALO icon
13
Halozyme
HALO
$9.79B
$23.7M 3.08%
1,471,498
+533,099
+57% +$8.64M
XENT
14
DELISTED
Intersect ENT, Inc
XENT
$23.2M 3.01%
720,240
+18,842
+3% +$583K
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$22.9M 2.97%
+439,635
New +$20.3M
AERI
16
DELISTED
Aerie Pharmaceuticals
AERI
$22.5M 2.93%
+474,066
New +$20.9M
VCYT icon
17
Veracyte
VCYT
$3.7B
$19.3M 2.51%
772,579
-750,826
-49% -$14.3M
TNDM icon
18
Tandem Diabetes Care
TNDM
$1.34B
$17M 2.21%
267,954
+4,071
+2% +$214K
LGND icon
19
Ligand Pharmaceuticals
LGND
$5.76B
$16.5M 2.15%
210,889
+59,595
+39% +$4.52M
XNCR icon
20
Xencor
XNCR
$1.5B
$15.9M 2.06%
511,328
+45,558
+10% +$1.52M
CDXS icon
21
Codexis
CDXS
$151M
$14.9M 1.93%
723,760
-335,599
-32% -$6.52M
NVTR
22
DELISTED
Nuvectra Corporation Common Stock
NVTR
$14.7M 1.91%
1,338,067
+175,616
+15% +$2.37M
KDNY
23
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$14.4M 1.87%
722,334
+8,543
+1% +$149K
DVAX
24
DELISTED
Dynavax Technologies
DVAX
$12.5M 1.62%
1,709,541
+1,364,202
+395% +$13.3M
VTRS icon
25
Viatris
VTRS
$20.4B
$9.24M 1.2%
325,905
+158,718
+95% +$4.63M
1
2 3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, First Light Asset Management held 67 positions worth $770M, up 23% from $627M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

First Light Asset Management's Q1 2019 filing shows 8 new, 35 increased, 18 reduced and 4 closed positions. Its largest new stake was Aerie Pharmaceuticals: 474,066 shares worth $22.5M. The largest sale was Shire pic, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 75% a quarter earlier, followed by Communication Services and Financials.

  • First Light Asset Management's largest Q1 2019 buy was Aerie Pharmaceuticals: 474,066 shares worth $22.5M.
  • First Light Asset Management added most to Dynavax Technologies in Q1 2019, an estimated $13.3M increase.
  • First Light Asset Management's biggest Q1 2019 reduction was Veracyte, cutting an estimated $14.3M.
  • First Light Asset Management fully exited Shire pic in Q1 2019, selling an estimated $28.4M.
  • First Light Asset Management's ten largest holdings make up 49% of its $770M portfolio in Q1 2019.
  • First Light Asset Management opened 8 new positions and closed 4 in Q1 2019.
  • First Light Asset Management's portfolio value rose 23% quarter-over-quarter to $770M.

Based on First Light Asset Management's 13F filing for Q1 2019, filed 15 May 2019.